Skylead Chemicals Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 03-12-2024
- Paid Up Capital ₹ 6.72 Cr
as on 03-12-2024
- Company Age 39 Year, 1 Month
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 19.65 Cr
as on 03-12-2024
- Satisfied Charges ₹ 9.70 Cr
as on 03-12-2024
- Revenue 18.21%
(FY 2018)
- Profit 86.76%
(FY 2018)
- Ebitda 79.83%
(FY 2018)
- Net Worth -0.80%
(FY 2018)
- Total Assets -5.23%
(FY 2018)
About Skylead Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.72 Cr.
The company currently has active open charges totaling ₹19.65 Cr. The company has closed loans amounting to ₹9.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hemlatta Rathod, Sugambhai Shah, and Parmar Jivanbhai serve as directors at the Company.
- CIN/LLPIN
L24110GJ1985PLC008225
- Company No.
008225
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Oct 1985
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bhavnagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Skylead Chemicals?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hemlatta Rathod | Additional Director | 17-May-2019 | Current |
Sugambhai Shah | Director | 18-Mar-2020 | Current |
Parmar Jivanbhai | Additional Director | 29-May-2017 | Current |
Financial Performance of Skylead Chemicals.
Skylead Chemicals Ltd, for the financial year ended 2018, experienced significant growth in revenue, with a 18.21% increase. The company also saw a substantial improvement in profitability, with a 86.76% increase in profit. The company's net worth dipped by a decrease of 0.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Skylead Chemicals?
In 2018, Skylead Chemicals had a promoter holding of 46.53% and a public holding of 53.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of Saurashtra Creation Date: 21 Jan 2002 | ₹1.50 M | Open |
Gujarat State Financial Corporation Creation Date: 17 Nov 2000 | ₹2.25 Cr | Open |
State Bank Of Saurashtra Creation Date: 19 Mar 1998 | ₹12.65 Cr | Open |
How Many Employees Work at Skylead Chemicals?
Skylead Chemicals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skylead Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skylead Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.